University Department of Surgery, Faculty of Medicine, University of Glasgow, Royal Infirmary, Glasgow, UK.
Ann Surg Oncol. 2011 Oct;18(10):2808-17. doi: 10.1245/s10434-011-1676-5. Epub 2011 Mar 24.
There is some evidence that a patient's pre-operative condition influences short-term and long-term post-operative outcomes. The aim of the present study is to compare the physiological and operative severity score for the enumeration of mortality and morbidity (POSSUM) and modified Glasgow prognostic score (mGPS) models in the prediction of post-operative outcome, both short term and long term, in patients undergoing resection of oesophago-gastric cancer.
Patients who underwent curative resection for oesophago-gastric cancer from January 2005 to May 2009 and who had data to score the POSSUM, P-POSSUM, O-POSSUM and mGPS models were included in the study. Observed morbidity and mortality rates were compared with predicted outcome in different risk groups. Both short-term outcome and long-term survival were recorded.
Observed morbidity was 49%, whereas POSSUM predicted post-operative morbidity in 60%, giving an overall standardised morbidity ratio of 0.82. Only male sex [hazard ratio (HR) 3.61, 95% confidence interval (CI) 1.38-9.46, P = 0.009] and POSSUM physiology score (HR 2.13, 95% CI 1.11-4.08, P = 0.023) were independently associated with post-operative morbidity. The post-operative mortality rates predicted by POSSUM, P-POSSUM and O-POSSUM were 16.5, 5.8 and 9.9%, respectively, giving a standardised mortality ratio of 0.25, 0.71 and 0.42. Only mGPS (HR 1.96, 95% CI 1.09-3.54, P = 0.025) and tumour-node-metastasis (TNM) stage (HR 2.21, 95% CI 1.44-3.38, P < 0.001) were independently associated with cancer-specific survival.
The POSSUM physiology score was useful in predicting post-operative morbidity, and the mGPS was useful in predicting cancer-specific survival, in patients undergoing surgery for oesophago-gastric cancer.
有证据表明,患者术前状况会影响短期和长期术后结局。本研究旨在比较生理学和手术严重程度评分用于死亡率和发病率评估(POSSUM)和改良格拉斯哥预后评分(mGPS)模型,以预测接受食管胃交界部癌切除术患者的短期和长期术后结局。
纳入 2005 年 1 月至 2009 年 5 月接受根治性切除术的食管胃交界部癌患者,这些患者的数据可用于评分 POSSUM、P-POSSUM、O-POSSUM 和 mGPS 模型。比较不同风险组的观察发病率和死亡率与预测结果。记录短期和长期生存情况。
观察到的发病率为 49%,而 POSSUM 预测术后发病率为 60%,标准化发病率比为 0.82。只有男性(危险比[HR]3.61,95%置信区间[CI]1.38-9.46,P=0.009)和 POSSUM 生理学评分(HR 2.13,95%CI 1.11-4.08,P=0.023)与术后发病率独立相关。POSSUM、P-POSSUM 和 O-POSSUM 预测的术后死亡率分别为 16.5%、5.8%和 9.9%,标准化死亡率比为 0.25、0.71 和 0.42。只有 mGPS(HR 1.96,95%CI 1.09-3.54,P=0.025)和肿瘤-淋巴结-转移(TNM)分期(HR 2.21,95%CI 1.44-3.38,P<0.001)与癌症特异性生存独立相关。
在接受食管胃交界部癌手术的患者中,POSSUM 生理学评分有助于预测术后发病率,mGPS 有助于预测癌症特异性生存。